SEC Form 4 · accession 0001193125-26-292642
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc H Hedrick
Officer — Chief Executive Officer · Director
Period of report
Jul 1, 2026
Accepted (ET)
Jul 1, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001095981
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Jul 1, 2026 | M | 6,387 | $0.00 | A | 34,431 | D | |
| Common StockF3,F1 | Jul 1, 2026 | M | 8,066 | $0.00 | A | 42,497 | D | |
| Common StockF4,F1 | Jul 1, 2026 | M | 1,986 | $0.00 | A | 44,483 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2 | $0.00 | Jul 1, 2026 | M | 6,387 | D | — | — | Common Stock | 6,387 | 163,650 | D |
| Restricted Stock UnitsF3 | $0.00 | Jul 1, 2026 | M | 8,066 | D | — | — | Common Stock | 8,066 | 155,584 | D |
| Restricted Stock UnitsF4 | $0.00 | Jul 1, 2026 | M | 1,986 | D | — | — | Common Stock | 1,986 | 153,598 | D |
Explanation of responses
- F1Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
- F2Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on October 1, 2025.
- F3Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on April 1, 2026.
- F4Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on July 1, 2026.